FR15C0055I1 - - Google Patents

Info

Publication number
FR15C0055I1
FR15C0055I1 FR15C0055C FR15C0055I1 FR 15C0055 I1 FR15C0055 I1 FR 15C0055I1 FR 15C0055 C FR15C0055 C FR 15C0055C FR 15C0055 I1 FR15C0055 I1 FR 15C0055I1
Authority
FR
France
Prior art keywords
cells
limbar
laminae
grafts
reconstructing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR15C0055I1 publication Critical patent/FR15C0055I1/fr
Application granted granted Critical
Publication of FR15C0055I2 publication Critical patent/FR15C0055I2/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0621Eye cells, e.g. cornea, iris pigmented cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/50Proteins
    • C12N2533/56Fibrin; Thrombin
FR15C0055C 2001-08-03 2015-07-29 Feuillets de l'epithelium corneen humain reconstitues in vitro et methode de production de ces derniers Active FR15C0055I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000476A ITRM20010476A1 (it) 2001-08-03 2001-08-03 Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento.
PCT/IT2001/000603 WO2003012083A1 (en) 2001-08-03 2001-11-28 In vitro reconstituted sheets of human corneal epithelium and method of producing the same

Publications (2)

Publication Number Publication Date
FR15C0055I1 true FR15C0055I1 (es) 2015-09-11
FR15C0055I2 FR15C0055I2 (fr) 2016-06-24

Family

ID=11455714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR15C0055C Active FR15C0055I2 (fr) 2001-08-03 2015-07-29 Feuillets de l'epithelium corneen humain reconstitues in vitro et methode de production de ces derniers

Country Status (12)

Country Link
US (1) US6610538B2 (es)
EP (1) EP1451302B1 (es)
AT (1) ATE397058T1 (es)
CY (1) CY1108257T1 (es)
DE (1) DE60134280D1 (es)
DK (1) DK1451302T3 (es)
ES (1) ES2307570T3 (es)
FR (1) FR15C0055I2 (es)
IT (1) ITRM20010476A1 (es)
NL (1) NL300754I2 (es)
PT (1) PT1451302E (es)
WO (1) WO2003012083A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186672A1 (en) * 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
US8187875B2 (en) * 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
KR100931887B1 (ko) * 2004-02-26 2009-12-15 리라이언스 라이프 사이언시스 프라이빗. 리미티드 각막 윤부에서 유도된 다능성 배아 유사 줄기 세포, 분리 방법 및 이들의 용도
US20060216821A1 (en) * 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
ITRM20040273A1 (it) * 2004-06-03 2004-09-03 Farmigea Spa Metodo per l'isolamento e l'espansione ex vivo di cellule staminali corneali umane e loro relativi usi.
EP1987133A2 (en) * 2006-02-24 2008-11-05 Reliance Life Sciences Pvt., Ltd. Conjunctival tissue system
WO2011040888A1 (en) * 2009-10-01 2011-04-07 Singapore Health Services Pte Ltd A biodegradable composition or combination and uses thereof
RU2505303C2 (ru) * 2011-09-13 2014-01-27 Общество с ограниченной ответственностью "Офтальмологические биотехнологии" Способ получения биотрансплантата для роговицы
FR2993282B1 (fr) 2012-07-13 2017-11-10 Expanscience Lab Procede d'identification de marqueurs moleculaires de la peau d'enfant
FR3011008B1 (fr) 2013-09-24 2017-12-29 Expanscience Lab Procedes d'evaluation des effets deleteres des uv sur la peau d'enfant
FR3016373B1 (fr) 2014-01-10 2018-01-19 Laboratoires Expanscience Modele de peau de mammelon reconstitue
FR3019186B1 (fr) 2014-03-31 2019-06-07 Laboratoires Expanscience Procedes d'evaluation des effets deleteres de l'urine sur la peau d'enfant
FR3045669B1 (fr) 2015-12-16 2019-04-05 Laboratoires Expanscience Procedes d'evaluation des effets de la deshydratation sur la peau d'enfant
FR3053053B1 (fr) 2016-06-23 2018-07-13 Laboratoires Expanscience Modeles de la dermatite atopique juvenile
FR3068045B1 (fr) 2017-06-22 2021-06-04 Expanscience Lab Modeles de peau sensible reconstituee
FR3133198A1 (fr) 2022-03-04 2023-09-08 Pierre Fabre Dermo-Cosmetique Modele de peau reconstituee
FR3138149A1 (fr) 2022-07-25 2024-01-26 Pierre Fabre Dermo-Cosmetique Méthode d’évaluation in vitro de l’activité photoprotectrice d’un actif

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255657B (it) 1992-05-29 1995-11-09 Colture di tessuto di mucosa congiuntivale differenziata, procedimentoper la loro preparazione e supporti per il loro uso.
US5827641A (en) 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
CA2227827A1 (en) 1998-01-23 1999-07-23 Unknown In vitro artificial cornea and sclera

Also Published As

Publication number Publication date
NL300754I2 (es) 2016-09-01
FR15C0055I2 (fr) 2016-06-24
ITRM20010476A1 (it) 2003-02-03
CY1108257T1 (el) 2014-02-12
PT1451302E (pt) 2008-09-08
ES2307570T3 (es) 2008-12-01
ATE397058T1 (de) 2008-06-15
DK1451302T3 (da) 2008-09-08
DE60134280D1 (de) 2008-07-10
WO2003012083A1 (en) 2003-02-13
US6610538B2 (en) 2003-08-26
ITRM20010476A0 (it) 2001-08-03
EP1451302A1 (en) 2004-09-01
EP1451302B1 (en) 2008-05-28
US20030027333A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
FR15C0055I1 (es)
AU2003295444A1 (en) Methods for in vitro expansion of hematopoietic stem cells
EP1425390A4 (en) MATERIALS AND TECHNIQUES FOR THE REPAIR OF NERVOUS TISSUES
AU4221399A (en) Human cd45+ and/or fibroblast + mesenchymal stem cells
GB2393734A (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
IL148060A0 (en) Compositions and methods for improved cell culture
CA2407439A1 (en) Individual venous valve prosthesis
EP2420567A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
WO2003105252A3 (en) CERAMIC ANODES AND PROCESS FOR PRODUCING THE SAME
WO2001011011A3 (en) Multipotent adult stem cells and methods for isolation
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
AU2003209259A8 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
WO2004050826A3 (en) Method of dynamically culturing embryonic stem cells
MY148759A (en) Methods to culture circovirus
AU2003288227A1 (en) Enzymatic production of (meth)acrylic esters that contain urethane groups
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
SI1456238T1 (sl) Proizvodnja f(ab)2 fragmentov v sesalskih celicah
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
WO2003100010A3 (en) Cytokine-free growth and maintenance of progenitor cells
WO2002033043A3 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells
AU2003233404A1 (en) Tissue engineering
AU7139501A (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier